This NDC is on FDA's drug shortage list (posted Dec 22, 2021)

Product Information

RIFAMPIN 150 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.9084 per EA under NDC 68180065806. Its NADAC has been published 670 times since Jan 22, 2014.

FDA first approved this application on Aug 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIFAMPIN 150 MG CAPSULE

rifampin
$0.9084per EA

Strength

150 mg/1

NDC

68180065806

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RIFAMPIN

Approval Type

Generic (ANDA)

FDA Application

ANDA090034

FDA Approved

8/21/2013

TE Code

AB

On Market Since

1/8/2014

Pharmacological Classes

Price Statistics

The NADAC for RIFAMPIN 150 MG CAPSULE has been published 670 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.9084 per EA
All-time high$1.3166 (Jan 10, 2024)
All-time low$0.5653 (Nov 20, 2024)
52-week high$0.9816
52-week low$0.5959
Median price$0.8246
Average price$0.8490
Largest weekly change+94.1% (Aug 19, 2020)
Weeks tracked670
Tracking sinceJan 22, 2014

Price History

1W

-7.5%

1M

+1.2%

3M

+13.1%

6M

+51.0%

1Y

+44.2%

3Y

-14.9%

5Y

-9.7%

All

+0.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIFAMPIN 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 150 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.9084 per EA (NDC 68180065806), effective Nov 18, 2026.

How has the price of RIFAMPIN 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIFAMPIN 150 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 670 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for RIFAMPIN 150 MG CAPSULE?

Since Jan 22, 2014, the NADAC for RIFAMPIN 150 MG CAPSULE has ranged from a low of $0.5653 (Nov 20, 2024) to a high of $1.3166 (Jan 10, 2024), with a median of $0.8246 per EA.

Are there cheaper alternatives to RIFAMPIN 150 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIFAMPIN 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures RIFAMPIN 150 MG CAPSULE?

RIFAMPIN 150 MG CAPSULE (NDC 68180065806) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.

Is RIFAMPIN 150 MG CAPSULE in shortage?

Yes — NDC 68180065806 is currently listed in FDA's drug shortage database (posted Dec 22, 2021).